Mechanical thrombectomy for the treatment of primary and secondary distal medium-vessel occlusion stroke: systematic review and meta-analysis

医学 冲程(发动机) 荟萃分析 溶栓 置信区间 改良兰金量表 脑出血 闭塞 子群分析 内科学 外科 心肌梗塞 缺血性中风 缺血 蛛网膜下腔出血 工程类 机械工程
作者
Aarón Rodríguez-Calienes,Juan Vivanco‐Suarez,J Sequeiros,Milagros Galecio‐Castillo,Cynthia Zevallos,Mudassir Farooqui,Santiago Ortega‐Gutiérrez
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:15 (e3): e460-e467 被引量:39
标识
DOI:10.1136/jnis-2022-019975
摘要

Background There is limited evidence on the indication and role of mechanical thrombectomy (MT) in patients with distal medium-vessel occlusions (DMVOs). The aim of this systematic review and meta-analysis was to evaluate all the evidence available on the efficacy and safety of MT techniques (stent retriever, aspiration) in primary and secondary DMVOs. Methods Five databases were searched from inception to January 2023 for studies of MT in primary and secondary DMVOs. Outcomes of interest included favorable functional outcome (90-day modified Rankin scale (mRS) 0–2), successful reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2b-3), symptomatic intracerebral hemorrhage (sICH), and 90-day mortality. Prespecified subgroup meta-analyses according to the specific MT technique and to the vascular territory (distal M2-M5, A2-A5, P2-P5) were also performed. Results A total of 29 studies with 1262 patients were included. For primary DMVOs (n=971 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 84% (95% confidence interval (CI) 76 to 90%), 64% (95% CI 54 to 72%), 12% (95% CI 8 to 18%), and 6% (95% CI 4 to 10%), respectively. For secondary DMVOs (n=291 patients), pooled rates of successful reperfusion, favorable outcome, 90-day mortality and sICH were 82% (95% CI 73 to 88%), 54% (95% CI 39 to 69%), 11% (95% CI 5 to 20%), and 3% (95% CI 1 to 9%), respectively. Subgroup analyses by MT technique and by vascular territory showed no differences in primary and secondary DMVOs. Conclusion Our findings suggest that MT using aspiration or stent retriever techniques appears to be effective and safe in primary and secondary DMVOs. However, given the level of evidence of our results, further confirmation in well-designed randomized controlled trials is needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
liuxinyu发布了新的文献求助10
刚刚
CPD应助小哀采纳,获得10
1秒前
yzr发布了新的文献求助10
2秒前
DZJ发布了新的文献求助10
2秒前
whl发布了新的文献求助10
2秒前
2秒前
leizhengyu完成签到 ,获得积分10
3秒前
3秒前
CipherSage应助zjcomposite采纳,获得10
4秒前
上官若男应助迷路画笔采纳,获得10
5秒前
许诺完成签到,获得积分10
5秒前
小雨发布了新的文献求助10
6秒前
ChiariRay完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
SHOUZHUO发布了新的文献求助10
8秒前
酷炫的汉堡完成签到,获得积分10
8秒前
刘天歌完成签到 ,获得积分10
8秒前
123完成签到,获得积分20
9秒前
冷酷从云完成签到,获得积分10
10秒前
好好好发布了新的文献求助10
10秒前
zzz完成签到,获得积分10
10秒前
干净的琦发布了新的文献求助30
12秒前
12秒前
染东发布了新的文献求助10
12秒前
细心的茗发布了新的文献求助10
12秒前
12秒前
李光完成签到,获得积分10
13秒前
13秒前
Ava应助dolla采纳,获得10
13秒前
15秒前
16秒前
orixero应助nffl采纳,获得10
16秒前
迷路画笔发布了新的文献求助10
17秒前
17秒前
大个应助称心的海冬采纳,获得10
17秒前
张蕊发布了新的文献求助10
17秒前
18秒前
Ting应助DZJ采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
晋绥日报合订本24册(影印本1986年)【1940年9月–1949年5月】 1000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6032480
求助须知:如何正确求助?哪些是违规求助? 7721223
关于积分的说明 16200379
捐赠科研通 5179205
什么是DOI,文献DOI怎么找? 2771703
邀请新用户注册赠送积分活动 1754977
关于科研通互助平台的介绍 1639993